购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

RGFP966

产品编号 T1762Cas号 1357389-11-7
别名 RGFP 966

RGFP966 是一种能够透过血脑屏障的高选择性HDAC3抑制剂,IC50为 80 nM。

RGFP966

RGFP966

纯度: 99.77%
产品编号 T1762 别名 RGFP 966Cas号 1357389-11-7

RGFP966 是一种能够透过血脑屏障的高选择性HDAC3抑制剂,IC50为 80 nM。

规格价格库存数量
1 mg¥ 315现货
2 mg¥ 453现货
5 mg¥ 738现货
10 mg¥ 946现货
25 mg¥ 1,930现货
50 mg¥ 3,490现货
100 mg¥ 4,970现货
1 mL x 10 mM (in DMSO)¥ 815现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"RGFP966"的相关化合物库

选择批次:
纯度:99.77%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
RGFP966 is an HDAC3 inhibitor (IC50: 0.08 μM) and does not affect other HDACs at concentrations up to 15 μM.
靶点活性
HDAC3:80 nM(cell free)
体外活性
RGFP966 对HDAC3具有特异性抑制作用 (IC50:0.08 μM),在高至15 μM的浓度下,对其他HDAC无有效抑制 [1]。在LPS/IFNγ刺激的RAW 264.7巨噬细胞中,RGFP966处理未改变TNFα、iNOS和IL-10基因的表达,但显著降低了促炎症基因IL-1β、IL-6和IL-12b的表达 [2]。此外,RGFP966在CTCL细胞系中减缓了细胞增长,此现象与DNA损伤和S期进程受损相关的增加的细胞凋亡有关 [3]。
体内活性
所有小鼠在经过可卡因条件性位置偏好(CPP)训练后,明显偏好于与可卡因相关联的环境。在无药物偏好测试后立即使用RGFP966(3或10 mg/kg,皮下注射)治疗,在第二次和第三次后测中显著减弱了CPP。其中,10 mg/kg的剂量显著快速降低了随后几天的CPP,而3 mg/kg的剂量则没有此效果[1]。RGFP966在10和25 mg/kg的剂量下,能改善旋转木马测试和开放场探索中的运动缺陷,并伴随着对纹状体体积的神经保护作用[4]。
激酶实验
Briefly, the respective human recombinant HDAC enzymes were incubated in the absence and/or in presence of various concentrations RGFP966 and a pro-fluorogenic substrate at room temperature for 60 min. Next, the deacetylation reaction was stopped by the addition of the HDAC Stop Solution (6 mg/ml trypsin, 0.3 mM SAHA) in all wells and the plate was incubated at 37 °C for 20 min. The release of the fluorescent 7-amino-4-methylcoumarin was monitored by measuring the fluorescence at λem = 460 nm and λex = 390 nm using a Synergy H1 plate reader. The fluorescence value of the background wells was subtracted from the fluorescence of the positive control, blank and inhibitor wells. Nonlinear regression was used to fit the data to the log(inhibitor) vs. response curve using GraphPad Prism [2].
细胞实验
To investigate the influence of the HDAC 3-selective inhibitor RGFP966 on cell viability, RAW 264.7 macrophages, HBE cells and hASM cells were seeded in 96-well plates. To obtain identical cell density at the start of the experiments, RAW 264.7 macrophages were seeded at 25,000 cells/cm2, HBE cells and hASM cells were seeded at 70% confluency (based on surface area) and were serum-starved for 24 h prior incubation with RGFP966. Shortly before incubation with RGFP966, the medium was replaced by 100 μl fresh (if appropriate serum free) culture medium. Incubations with LPS and IFNγ were performed as described for HDAC 1–3 downregulation by siRNA. After 20 h of incubation with RGFP966, 20 μl of CellTiter 96 AQueous One Solution reagent was added to each well and incubated at 37 °C for 1 h in the dark. The absorbance at 490 nm was measured using a Synergy H1 plate reader. LPS/IFNγ-stimulated cells without addition of RGFP966 were considered 100% [2].
动物实验
Subthreshold training and a 24-h retention test for location-dependent object recognition memory (OLM) and novel object recognition memory (ORM) were performed as described previously. Mice received an injection of RGFP966 (3, 10, or 30 mg/kg s.c) or vehicle alone either 1 h before or immediately after a 3-min training seeion [1].
别名RGFP 966
化学信息
分子量362.4
分子式C21H19FN4O
CAS No.1357389-11-7
储存&溶解度
存储store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
DMSO: 45 mg/mL (124.17 mM)
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM2.7594 mL13.7969 mL27.5938 mL137.9691 mL
5 mM0.5519 mL2.7594 mL5.5188 mL27.5938 mL
10 mM0.2759 mL1.3797 mL2.7594 mL13.7969 mL
20 mM0.1380 mL0.6898 mL1.3797 mL6.8985 mL
50 mM0.0552 mL0.2759 mL0.5519 mL2.7594 mL
100 mM0.0276 mL0.1380 mL0.2759 mL1.3797 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

Related Tags: buy RGFP966 | purchase RGFP966 | RGFP966 cost | order RGFP966 | RGFP966 chemical structure | RGFP966 in vivo | RGFP966 in vitro | RGFP966 formula | RGFP966 molecular weight